Research Article
Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome
Table 1
The study group characteristics.
| | | HOMA < 2.0, N = 446 (52.2%) | HOMA > 2.0, N = 408 (47.8%) | |
| | Age (years) | 26 ± 5 | 26 ± 6 | 0.91 | | BMI (kg/m2) | 23.0 ± 4.4 | 30.5 ± 7.9 | <0.001 | | Overweight (N; %) | 68; 15.2 | 81; 19.8 | 0.08 | | Obesity (N; %) | 35; 7.8 | 211; 51.7 | <0.001 | | Glucose (mg/dL) | 86.0 (81.0–90.0) | 91.0 (86.0–97.0) | <0.001 | | Impaired fasting glucose (N; %) | 4; 0.9 | 76; 18.6 | <0.001 | | Insulin (μIU/mL) | 6.1 (4.7–7.6) | 13.3 (10.9–18.2) | <0.001 | | SHBG (nmol/L) | 49.1 (34.1–68.2) | 30.8 (20.7–44.5) | <0.001 | | SHBG < 26.1 (nmol/L) (N; %) | 55; 12.3 | 160; 39.2 | <0.001 | | OR impaired fasting glucose | Ref. | 25.3 (9.1–69.9) | <0.001 | | OR SHBG < 26.1 (nmol/L) | Ref. | 4.56 (3.23–6.45) | <0.001 |
|
|
Mean ± standard deviation or median (lower quartile–upper quartile) or 95% confidence interval for OR.
|
